Valorization addendum 195 Figure 1 The aforementioned research program This public-private collaboration is aimed at gathering knowledge and data that will help patients benefit from the potential advantages of optical spectroscopy. By examining the issues and addressing the unknowns together, the program shares the cost and risk factors associated with early phases of development. Each partner in this open innovation platform contributes specific knowledge and expertise to achieve a common goal: optimizing the use of optical spectroscopy in medicine. Risks, costs, facilities and data are shared between all participants, so that advancements can be made more effectively. This approach provides a solid base that outlines the basic principles of how the technology works, and enables each individual industrial partner to use those principles for application in their product development process. This structure matches with the intention of the European Union to stimulate Responsible Research and Innovation that bridges the gap between science and society5.
proefschrift_Schols_SLV
To see the actual publication please follow the link above